Navigation Links
Researchers seeking to identify Alzheimer's risk focus on specific blood biomarker
Date:9/9/2008

NEW YORK A simple blood test to detect whether a person might develop Alzheimer's disease is within sight and could eventually help scientists in their quest toward reversing the disease's onset in those likely to develop the debilitating neurological condition.

Building on a study that started 20 years ago with an elderly population in Northern Manhattan at risk or in various stages of developing Alzheimer's disease, the Columbia research group has yielded ground-breaking findings that could change the way the disease is treated or someday prevent it. These findings suggest that by looking at the blood doctors may be able to detect a person's predisposition to developing the dementia-inducing disease that robs a person of their memory and ability carry out tasks essential to life.

Results presented online in the Proceedings of the National Academy of Sciences during the week of Sept. 8, 2008 suggest that individuals with elevated levels of a certain peptide in the blood plasma, Amyloid Beta 42 (A42), are at increased risk of developing Alzheimer's disease and that the decline of A42 in the bloodstream may reflect the compartmentalization or "traffic jam" of A42 in the brain, which occurs in the brain's of people with Alzheimer's.

"To date, A42 levels have measured most reliably in the cerebrospinal fluid, which is more difficult to collect than blood," said Nicole Schupf, Ph.D., Dr.P.H., associate professor of clinical epidemiology at Columbia University Medical Center and lead author of the paper. "Blood draws can be done with relative ease and greater frequency than spinal taps, which is typically the way cerebrospinal fluid is collected."

In this study, researchers found that plasma levels of A42 appear to increase before the onset of Alzheimer's disease and decline shortly after the onset of dementia. Researchers surmise that A42 may become trapped in the brain, which could account for the decrease in levels p
'/>"/>

Contact: Alex Lyda
mal2133@columbia.edu
212-305-0820
Columbia University Medical Center
Source:Eurekalert  

Page: 1 2

Related biology news :

1. ISU researchers help map first plant-parasitic nematode genome sequence
2. Collaboration between researchers yields more comprehensive portrait of brain cancer
3. Tel Aviv University researchers create new stem cell screening tool
4. Hopkins researchers piece together gene network linked to schizophrenia
5. TGen and Washington University researchers discover new approach to treating endometrial cancer
6. Researchers devise means to create blood by identifying earliest stem cells
7. Researchers discover atomic bomb effect results in adult-onset thyroid cancer
8. Antidepressants need new nerve cells to be effective, UT Southwestern researchers find
9. Indiana U researchers launch social networking and research management tool for scientists
10. UC Davis researchers define characteristics, treatment options for XXYY syndrome
11. Munich researchers discover key allergy gene

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers seeking to identify Alzheimer's risk focus on specific blood biomarker
Researchers seeking to identify Alzheimer's risk focus on specific blood biomarker
(Date:11/4/2009)... out, hold the power to help militaries and muniti... toxic waste on test sites. , Compounds known as...in World War II and have been used in military mun...re often used to propel tank shells and act like a...eased knowledge of their environmentally harmful e...
(Date:11/4/2009)...swire/ -- DigitalPersona, Inc., a leader in finger... announced that WAND Corporation, a leading suppli...ce restaurants, has integrated DigitalPersona tech...tions. WAND,s quick-service customers can now use ...lity and deter unauthorized manager overrides. A...
(Date:11/4/2009)...obal Rainmakers, Inc., an intellectual property ho...ay announced that the company has exited its "stea...e its suite of technologies designed to leverage c...ring the past four years, the company has spent te...series of core--but expandable--technologies built...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3CRGT Sponsors Teardrops to Rainbows Golf Tournament 56541 1CRGT Sponsors Teardrops to Rainbows Golf Tournament 56541 2Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 1Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 2Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 3Go and Good Things Happen with 28BUGABOO 29 28RED 29 56537 4NephroGenex Announces Full Enrollment in New Pyridorin 28TM 29 Clinical Trial PYR 210 56533 1NephroGenex Announces Full Enrollment in New Pyridorin 28TM 29 Clinical Trial PYR 210 56533 2
...olecular Biology Organization (EMBO) announced tha...m the University of Konstanz, Germany, will receiv...e Sciences. EMBO awards the prize annually to a pr...nication with the public. Axel Meyer receives the ...o convey complex scientific topics to the general ...
...iversity of Rochester,s Eastman School of Music an...developed a unique test for perfect pitch, and hav... that perfect pitchthe ability to recognize and re...h more common in non-musicians than scientists had...ople because without extensive musical training it...
...ust 25, 2008Borrowing and sharing of prescription ... concern. A survey of nearly 7,500 women of repro...ng more than one-third of this population, accordi... Journal of Women,s Health , a peer-reviewed journ...s available free online at http://www.liebertonli...
Other Biology News:Prominent German biologist wins EMBO Communication Award 2'Perfect pitch' in humans far more prevalent than expected 2'Perfect pitch' in humans far more prevalent than expected 3Trends in prescription medication sharing among reproductive-aged women 2
(Date:11/6/2009)...or Arrowhead’s 2010 Personalized Medicine Pa...on February 22-24, 2010 in Philadelphia, has been ...ghlight key issues in forming partnerships and eng... , Minneapolis, MN (PRWEB)...o;s 2010 Personalized Medicine Partnerships Confe...
(Date:11/5/2009)...rstCall/ -- Imagenetix, Inc. (OTC Bulletin Board: ...dent and CEO of Imagenetix, will be presenting the...ence on Thursday, December 3rd, at 10:30 AM PST at...CRO ,, LD MICRO is a by-invitation only newslet...nies in the micro-cap space. Since 2002, the firm ...
(Date:11/5/2009)...swire-FirstCall/ -- Cepheid (Nasdaq: CPHD ) today... the following investor conferences, and invited i... Credit Suisse Healthcare Conference, Phoeni... at 10 a.m. Mountain Time, NASDAQ... Tuesday, 1 December, 2009 at 10.45 a.m....
(Date:11/5/2009)...5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Corp...ompany") today announced,that the Company plans to...onday, November 9, 2009, after the market closes. ... at 5:00 pm ET on November 9, 2009,to discuss thir...call by,dialing 1-888-713-4211 or 1-617-213-4864 f...
Breaking Biology Technology:Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Cepheid to Webcast Upcoming Financial Presentations 2BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...y, LLC announced,today that two new managing direc...firm in July 2007 as Managing Director and,Associa...uates the,intellectual property portfolios of pote...works in tandem with current investment companies ...perty positions. Mr. Perez,joined Third Security f...
... forward in Phase III development, NEW YORK, Aug.... licensing agreement for acadesine with Schering-P...ent grants Schering-Plough exclusive,worldwide rig...eriCor,s,lead compound, acadesine. Financial terms... is currently under evaluation in Phase III clinic...
...nter for Molecular,Medicine (CMM) today said it wa...ursing mothers for codeine risks cited in a Friday...(FDA). Late Friday, the FDA issued an advisory no...s, side effect in nursing infants whose mothers ar...zers of that drug. The FDA,advisory recommended ph...
Other Biology Technology:Third Security, LLC Hires Two New Managing Directors 2PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation 2PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation 3Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers 2
MoDC Cell Chip-IHC from 3H Biomedical AB
Isotetrandrine from Calbiochem
...ipetting is increasingly essential for reducing sa... biochemical applications. The eight-channel nano2...eled in the industry. ,Features: , Real-time doc...d volumes , Automated diagnostics detect and corre...
Microtiter Wells from Bethyl Laboratories
Biology Products: